These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38448251)

  • 21. Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.
    Hull LE; Haas JS; Simon SR
    Am J Prev Med; 2018 Feb; 54(2):221-228. PubMed ID: 29241717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Implementing B-RST
    Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
    Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes-Practice resource of the National Society of Genetic Counselors.
    Berliner JL; Cummings SA; Boldt Burnett B; Ricker CN
    J Genet Couns; 2021 Apr; 30(2):342-360. PubMed ID: 33410258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unselected Women's Experiences of Receiving Genetic Research Results for Hereditary Breast and Ovarian Cancer: A Qualitative Study.
    Forbes Shepherd R; Forrest LE; Tutty E; Pearce A; Devereux L; James PA; Campbell IG; Trainer A; Young MA
    Genet Test Mol Biomarkers; 2021 Dec; 25(12):741-748. PubMed ID: 34918982
    [No Abstract]   [Full Text] [Related]  

  • 26. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
    Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
    Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
    Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
    J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.
    Katapodi MC; Munro ML; Pierce PF; Williams RA
    Nurs Res; 2011; 60(6):368-77. PubMed ID: 22048556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-based genetic testing for Women's cancer prevention.
    Evans O; Gaba F; Manchanda R
    Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():139-153. PubMed ID: 32245629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing landscape of hereditary breast and ovarian cancer germline genetic testing in Australia.
    Petelin L; James PA; Trainer AH
    Intern Med J; 2018 Oct; 48(10):1269-1272. PubMed ID: 30288903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
    Kinney AY; Howell R; Ruckman R; McDougall JA; Boyce TW; Vicuña B; Lee JH; Guest DD; Rycroft R; Valverde PA; Gallegos KM; Meisner A; Wiggins CL; Stroup A; Paddock LE; Walters ST
    Contemp Clin Trials; 2018 Oct; 73():123-135. PubMed ID: 30236776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility.
    Rowley SM; Mascarenhas L; Devereux L; Li N; Amarasinghe KC; Zethoven M; Lee JEA; Lewis A; Morgan JA; Limb S; Young MA; James PA; Trainer AH; Campbell IG
    Genet Med; 2019 Apr; 21(4):913-922. PubMed ID: 30254378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits.
    Nazareth S; Hayward L; Simmons E; Snir M; Hatchell KE; Rojahn S; Slotnick RN; Nussbaum RL
    Obstet Gynecol; 2021 Dec; 138(6):860-870. PubMed ID: 34735417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Young Women's Perceptions Regarding Communication with Healthcare Providers About Breast Cancer, Risk, and Prevention.
    Lunsford NB; Sapsis KF; Smither B; Reynolds J; Wilburn B; Fairley T
    J Womens Health (Larchmt); 2018 Feb; 27(2):162-170. PubMed ID: 28472603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary breast and ovarian cancer syndrome: considering the complexities.
    Senter L
    Curr Probl Cancer; 2014; 38(6):226-34. PubMed ID: 25497409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "It wasn't just for me": Motivations and implications of genetic testing for women at a low risk of hereditary breast and ovarian cancer syndrome.
    Gill G; Beard C; Storey K; Taylor S; Sexton A
    Psychooncology; 2020 Aug; 29(8):1303-1311. PubMed ID: 32497346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementing a Population-Based Breast Cancer Risk Assessment Program.
    Silver E; Wenger N; Xie Z; Elashoff D; Lee K; Madlensky L; Trent J; Petruse A; Johansen L; Naeim A
    Clin Breast Cancer; 2019 Aug; 19(4):246-253.e2. PubMed ID: 31072694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families].
    Singer CF; Tea MK; Pristauz G; Hubalek M; Rappaport C; Riedl C; Helbich T
    Wien Klin Wochenschr; 2012 May; 124(9-10):334-9. PubMed ID: 22644217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.
    Morgan D; Sylvester H; Lucas FL; Miesfeldt S
    Fam Cancer; 2009; 8(4):277-87. PubMed ID: 19347608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary breast and ovarian cancer: referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the community setting.
    Morgan D; Sylvester H; Lucas FL; Miesfeldt S
    Genet Med; 2010 Jan; 12(1):25-31. PubMed ID: 20027114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.